Hospital Medicine (Inpatient Only)
525 East 68th Street
New York, NY 10065
Already a patient?
Login or sign-upto Connect Patient Portal to make an appointment
Eva Flores, M.D.
Hospital Medicine
Locations and Appointments
Insurances Accepted
Please contact the doctor's office to verify that your insurance is accepted.
AETNA
Aetna - NYP
Amida Care
Anthem Blue Cross Blue Shield
Anthem Blue Cross/Blue Shield
Anthem Blue Cross/Blue Shield Healthplus
CIGNA
EmblemHealth
Fidelis Care
GHI
Health Insurance Plan of NY (HIP)
Healthfirst
Healthspring
Local 1199
Molina Healthcare
Oxford Health Plans
Quality Health Management (QHM)
Rockefeller University/Luminare
United Healthcare
UnitedHealthcare
VNS Health
VNSNY CHOICE
WellCare
WorldWide Medical
About Eva Flores, M.D.
Eva Flores is a hospitalist who cares for hospitalized patients only and does not have out-patient practices.
Eva Flores is board certified in internal medicine. Her academic interests are in medical consultation and hospital medicine.
Board Certifications
- Internal Medicine
Education
- Medical School: New York University School of Medicine
- Residency: New York University School of Medicine
Languages
- English
Titles & Positions
- Assistant Attending Physician
- Assistant Professor of Clinical Medicine
Hospital Affiliations
- NewYork-Presbyterian / Weill Cornell Medical Center
- NewYork-Presbyterian Lower Manhattan Hospital
Education
- Medical School: New York University School of Medicine
- Residency: New York University School of Medicine
Titles & Positions
- Assistant Attending Physician
- Assistant Professor of Clinical Medicine
Board Certifications
- internal medicine
Languages Spoken
- english
Research
Usefulness of mid-regional proadrenomedullin levels in the resuscitation phase of severely burned patients and its utility in early sepsis detection.
March 08, 2024Preoperative Management of Medications for Rheumatologic and HIV Diseases: Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement.
August 01, 2022Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
August 27, 2017